Results 41 to 50 of about 1,110,432 (191)

The challenge of measuring IL-33 in serum using commercial ELISA: lessons from asthma [PDF]

, 2016
Background Interleukin-33 (IL-33) has been subject of extensive study in the context of inflammatory disorders, particularly in asthma. Many human biological samples, including serum, have been used to determine the protein levels of IL-33, aiming to ...
Afonina, Asaka, Grotenboer, Guo, Hamzaoui, Licona-Limon, Portelli, Prefontaine, Rivière, Voloshyna   +9 more
core   +7 more sources

Interrelationship and Sequencing of Interleukins4, 13, 31, and 33 – An Integrated Systematic Review: Dermatological and Multidisciplinary Perspectives

Journal of Inflammation Research, 2022
Alin Laurentiu Tatu,1– 3,* Thomas Nadasdy,3,4 Anca Arbune,5,* Valentin Chioncel,6,* Carmen Bobeica,7 Elena Niculet,3,* Alina Viorica Iancu,7 Caterina Dumitru,8 Valentin Tudor Popa,3,9 Nicolas Kluger,10,11 Victor Gabriel Clatici,11 Claudiu
Tatu AL, Nadasdy T, Arbune A, Chioncel V, Bobeica C, Niculet E, Iancu AV, Dumitru C, Popa VT, Kluger N, Clatici VG, Vasile CI, Onisor C, Nechifor A   +13 more
doaj  

Interleukin-33 regulates tissue remodelling and inhibits angiogenesis in the eye [PDF]

, 2016
Age-related macular degeneration (AMD) is the leading cause of central vision loss worldwide. Loss of retinal pigment epithelium (RPE) is a major pathological hallmark in AMD with or without pathological neovascularization.
Allakhverdi, Barbour, Bell, Campbell, Carriere, Carver, Cayrol, Chackerian, Chen, Chen, Choi, Daniels, Demyanets, Dick, Doyle, Doyle, Doyle, Dunn, Forrester, Friedlander, Fu, Guidry, Kakkar, Kuchler, Lamkanfi, Lamkanfi, Lavalette, Lefrancais, Leung, Liew, Liu, Luthi, Martin, McMenamin, Miller, Nussenblatt, Oboki, Pichery, Rein, Schmitz, Wei, Wu, Xi, Xu, Xu, Xu, Xu, Yanagisawa   +47 more
core   +3 more sources

IL-33 Attenuates Sepsis by Inhibiting IL-17 Receptor Signaling through Upregulation of SOCS3

Cellular Physiology and Biochemistry, 2017
Background/Aims: Sepsis is a systemic inflammatory response during infection. There are limited therapeutic options for sepsis patients. Interleukin (IL)-33 has been reported recently with a beneficial effect in mouse sepsis.
Ran Lv, Jinning Zhao, Min Lei, Dongju Xiao, Yijin Yu, Junran Xie   +5 more
doaj   +1 more source

A Machine Learning Model for Predicting Recurrent Pregnancy Loss: Retrospective Integration of Routine Serum IL-33, C-Reactive Protein, and Lymphocyte Subset Counts [PDF]

Int J Gen Med
Qiuxia Liu Liu, Liyun Dong
openalex   +2 more sources

IL-33 and IL-33-derived DC-based tumor immunotherapy

Experimental and Molecular Medicine
Interleukin-33 (IL-33), a member of the IL-1 family, is a cytokine released in response to tissue damage and is recognized as an alarmin. The multifaceted roles of IL-33 in tumor progression have sparked controversy within the scientific community ...
Myeong-Ho Kang, Yong-Soo Bae
doaj   +1 more source

Molecular Basis of Selective Cytokine Signaling Inhibition by Antibodies Targeting a Shared Receptor

Frontiers in Immunology, 2021
Interleukin-1 (IL-1) family cytokines are potent mediators of inflammation, acting to coordinate local and systemic immune responses to a wide range of stimuli. Aberrant signaling by IL-1 family cytokine members, however, is linked to myriad inflammatory
James K. Fields, James K. Fields, James K. Fields, Kyle Kihn, Gabriel S. Birkedal, Erik H. Klontz, Erik H. Klontz, Erik H. Klontz, Kjell Sjöström, Sebastian Günther, Robert Beadenkopf, Göran Forsberg, David Liberg, Greg A. Snyder, Greg A. Snyder, Daniel Deredge, Eric J. Sundberg   +16 more
doaj   +1 more source

Serum IL-33, a new marker predicting response to rituximab in rheumatoid arthritis [PDF]

, 2016
Background. Recent works have suggested a possible link between IL-33 and B-cell biology. We aimed to study in different cohorts and with an accurate ELISA assay the possible association between serum IL-33 detection and response to rituximab (RTX) in ...
A Ahmed, Alice Courties, AM Gestel van, B Stolarski, Barbara Tolusso, Bineta Ly, D Talabot-Ayer, D Xu, D Xu, E Kunisch, E Rivière, E-J Lee, Edward M. Vital, Elodie Rivière, F Rivellese, FY Liew, Gianfranco Ferraccioli, Houria Hendel Chavez, J Malcolm, J Schmitz, J Sellam, J Sellam, J Sellam, J Shen, Jérémie Sellam, M Broek van den, M Couderc, M Komai-Koma, Martin Soubrier, Maxime Dougados, NL Millar, P Martin, Paul Emery, Paul-Olivier Rouzaire, S Sattler, SK Athari, TC Theoharides, X Mariette, Xavier Mariette, Yassine Taoufik, Z Xiangyang   +40 more
core   +6 more sources

The Novel Role of MIF in the Secretion of IL-25, IL-31, and IL-33 from PBMC of Patients with Rheumatoid Arthritis

Molecules, 2021
Rheumatoid arthritis (RA) is an autoimmune inflammatory joint disease with complex pathogenesis associated with cytokine dysregulation. Macrophage migration inhibitory factor (MIF) plays a role in systemic inflammation and joint destruction in RA and ...
Samuel García-Arellano, Luis Alexis Hernández-Palma, Sergio Cerpa-Cruz, Gabriela Athziri Sánchez-Zuno, Melva Guadalupe Herrera-Godina, José Francisco Muñoz-Valle   +5 more
doaj   +1 more source

IL-31 and IL-33 in rheumatoid arthritis patients

Научно-практическая ревматология, 2022
Objective – to investigate clinical and diagnostic significance of IL-31 and IL-33 determination in patients with rheumatoid arthritis (RA).Material and methods. 154 patients with a reliable diagnosis of RA were examined.
N. A. Lapkina, A. A. Baranov, N. E. Abaytova, N. Yu. Levshin, O. P. Rechkina, E. A. Leontyeva, A. S. Avdeyeva, A. S. Artyukhov, E. L. Nasonov   +8 more
doaj   +1 more source